101 – 110 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Life satisfaction in Parkinson's disease - associated factors
2016) The 20th International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Perceived walking difficulties in relation to motor aspects in Parkinson’s disease
2016) 4th World Parkinson Congress(
- Contribution to conference › Abstract
-
Mark
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Praktische Anwendung der Levodopa-Pumpe
(
- Contribution to journal › Scientific review
-
Mark
Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease : For Whom, When, and How?
(
- Contribution to journal › Scientific review
-
Mark
Non-oral dopaminergic therapies for Parkinson's disease : current treatments and the future
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany
(
- Contribution to journal › Article
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
(
- Contribution to journal › Article
-
Mark
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
(
- Contribution to journal › Scientific review